Alcaftadine
- Generic Name
- Alcaftadine
- Brand Names
- Lastacaft
- Drug Type
- Small Molecule
- Chemical Formula
- C19H21N3O
- CAS Number
- 147084-10-4
- Unique Ingredient Identifier
- 7Z8O94ECSX
- Background
Alcaftadine is a H1 histamine receptor antagonist indicated for the prevention of itching associated with allergic conjunctivitis. This drug was approved in July 2010.
- Indication
用于2岁以上人群过敏性结膜炎相关性眼部瘙痒的治疗。
- Associated Conditions
- Allergic Conjunctivitis (AC)
- Associated Therapies
- -
Ocular Allergy Treatment Practical Impact Trial
- First Posted Date
- 2013-03-11
- Last Posted Date
- 2013-05-30
- Lead Sponsor
- Starx Research Center, LLC
- Target Recruit Count
- 50
- Registration Number
- NCT01808768
- Locations
- 🇺🇸
STARx, Springfield, New Jersey, United States
🇺🇸STARx Research Center, Edison, New Jersey, United States
Safety and Efficacy Study of a Eye Drop for Eye Allergy
- First Posted Date
- 2009-04-28
- Last Posted Date
- 2015-03-06
- Lead Sponsor
- Vistakon Pharmaceuticals
- Target Recruit Count
- 60
- Registration Number
- NCT00889330
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath